Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M101,248Revenue (TTM) $M37,533Net Margin (%)3.3Altman Z-Score1.3
Enterprise Value $M121,908EPS (TTM) $0.5Operating Margin %9.3Piotroski F-Score5
P/E(ttm)86.3Beneish M-Score-2.4Pre-tax Margin (%)7.0Higher ROA y-yN
Price/Book71.610-y EBITDA Growth Rate %-1.7Quick Ratio0.6Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %-8.2Current Ratio0.9Lower Leverage y-yY
Price/Free Cash Flow19.4y-y EBITDA Growth Rate %-64.9ROA % (ttm)1.6Higher Current Ratio y-yN
Dividend Yield %4.8PEG--ROE % (ttm)46.7Less Shares Outstanding y-yN
Payout Ratio %1,373Shares Outstanding M2,436ROIC % (ttm)8.7Gross Margin Increase y-yY

Gurus Latest Trades with GSK

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

GSK is held by these investors:



GSK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$2288.91view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.1496.59view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29685.63view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$12246.33view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$14196.86view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$12246.33view

Press Releases about GSK :

Quarterly/Annual Reports about GSK:

    News about GSK:

    Articles On GuruFocus.com
    Gilead Sciences Raises Dividend by Double Digits Feb 22 2017 
    If You Want Yield, Look to the UK Feb 19 2017 
    Flood of News Presents Buying Opportunity Jan 17 2017 
    Gilead Sciences Must Answer to Investors After a Disappointing 2016 Jan 05 2017 
    GlaxoSmithKline, Vodafone Hit 3-Year Low Prices Dec 24 2016 
    Asset Sales, New Projects Fuel 6.7% Yield Dec 07 2016 
    Robust Pipeline Supports 5.5% Dividend Yield Dec 05 2016 
    Jeff Auxier Curbs Multiple Positions in 3rd Quarter Dec 01 2016 
    Tweedy Browne Fund Investment Adviser's Semi-Annual Letter to Shareholders Nov 28 2016 
    6 Worthy Dividend Stocks Down 10% or More Nov 22 2016 

    More From Other Websites
    Top Ranked Growth Stocks to Buy for February 23rd Feb 23 2017
    Bayer (BAYRY) Misses on Q4 Earnings; Revenues in Line Feb 23 2017
    Positive Results for Relvar® Ellipta® Lung Function Study in Patients with Well-Controlled Asthma Feb 23 2017
    Pfizer's Leukemia Candidate Gets Priority Review in U.S. Feb 22 2017
    Gilead, Glaxo Pitted In HIV Battle; Both Struggle Vs. Standard Drugs Feb 22 2017
    Biotech: What's Next For Gilead, Glaxo, and Merck HIV Treatments Feb 22 2017
    Korn Ferry Futurestep Partners with GlaxoSmithKline to Support Talent Acquisition Feb 21 2017
    If You Want Yield, Look to the UK Feb 19 2017
    Shire (SHPG) Beats on Q4 Earnings, Sales; Gives Upbeat View Feb 17 2017
    Could BP plc and GlaxoSmithKline plc help you retire early? Feb 17 2017
    Zoetis (ZTS) Beats Q4 Earnings Estimates, Lowers Outlook Feb 16 2017
    Alexion (ALXN) Q4 Earnings In-Line, Sales Rise Y/Y Feb 16 2017
    GlaxoSmithKline’s Valuation Compared to Its Peers Feb 16 2017
    GlaxoSmithKline’s Consumer Healthcare Reports Growth in 4Q16 Feb 16 2017
    3 hot dividend stocks I’d buy in March Feb 16 2017
    British Blue Chips Snub Investor Calls to Show CEO Pay Ratio Feb 16 2017
    GlaxoSmithKline’s Vaccines Business Reported Growth in 4Q16 Feb 15 2017
    AMAG Pharma (AMAG) Incurs Loss in Q4, Revenues Lag Estimates Feb 15 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)